PPB Pharmacist Pre-registration Exam study materials
PPB Pharmacist Pre-registration Exam study resources

PPB Pharmacist Pre-registration Exam study plan

PPB Pharmacist Pre-registration Exam · Give each week a clear focus.

8 weeks · About 7 hours per week

Week 1

Registration and Marketing Authorisation (MA)

  • Map the full MA lifecycle from pre-submission to post-authorisation variation, listing each regulatory step and its required documentation in your own notes

  • Distinguish national, decentralised, mutual recognition and centralised procedures, and state which application type fits three given product scenarios

  • Classify five example product changes as Type IA, Type IB or Type II variations and justify each classification

  • Explain the structure and purpose of the Common Technical Document modules and identify which module holds quality, safety and efficacy data

  • Draft a one-page checklist of the dossier sections a candidate would expect to see in a new marketing authorisation application

Your checkpoint

A two-page MA procedure comparison table plus a variation classification log covering at least ten worked examples

Week 2

Registration and Marketing Authorisation (MA) & Quality Control (Lab and Lot Release)

  • Link MA dossier quality requirements to the pharmacopoeial and specification controls that support them

  • Describe how active substance and finished product specifications are set, including acceptance criteria and justification

  • Explain validation of analytical methods by listing the parameters assessed and when revalidation is triggered

  • Outline the lot release pathway for a biological product and identify which tests require independent laboratory confirmation

  • Compare in-house, contract and official control laboratory roles in release testing

Your checkpoint

A one-page flowchart connecting dossier quality data through specification setting to lot release, with a short written rationale for each decision point

Week 3

Quality Control (Lab and Lot Release) & Regulatory Inspections

  • Interpret out-of-specification and out-of-trend results and describe the investigation sequence expected before a batch decision

  • Explain stability study design, including bracketing and matrixing, and state what shelf-life claims they support

  • Prepare for an inspection by listing the documentation an inspector would request in a quality control laboratory

  • Describe how inspection findings are graded, from critical to minor, and outline a corrective and preventive action plan for one critical finding

  • Identify the difference between routine, for-cause and pre-approval inspections and what triggers each

Your checkpoint

A simulated OOS investigation report with root cause, CAPA and batch disposition decision, plus an inspection readiness checklist of at least fifteen items

Week 4

Regulatory Inspections & Licensing, Good Pharmacy Practice, Training & Continuing Professional Development (CPD)

  • Map the licensing requirements for a pharmacy premises, including the responsible pharmacist role and conditions attached to a licence

  • Explain good pharmacy practice standards for dispensing, storage, cold chain and record keeping, and self-audit against them

  • Build a personal CPD cycle, recording a learning need, planned activity, reflection and outcome for one real activity

  • Describe how training records and competence assessments are evidenced during an inspection

  • State the actions a responsible pharmacist must take when a licence condition is breached or a serious incident occurs

Your checkpoint

A completed CPD record for one activity plus a premises self-audit scored against at least ten good pharmacy practice standards

Week 5

Clinical Trials

  • Outline the clinical trial authorisation route, listing the submissions and approvals needed before first participant in

  • Explain the roles and legal responsibilities of sponsor, investigator, monitor and ethics committee across a trial

  • Apply informed consent requirements to two scenarios, including a vulnerable participant, and state what makes consent valid

  • Describe good clinical practice requirements for source data, case report forms and investigational product accountability

  • Classify three safety events as adverse event, serious adverse event or suspected unexpected serious adverse reaction and state the reporting timelines

Your checkpoint

A trial site file index with a written justification for each essential document, plus three worked safety reporting cases with timelines

Week 6

Vigilance (Pharmacovigilance)

  • Describe the pharmacovigilance system and its quality requirements, including the role of the qualified person responsible for pharmacovigilance

  • Distinguish individual case safety reports from periodic safety reports and state the reporting timelines and routes for each

  • Explain signal detection and how a signal is validated, prioritised and followed by regulatory action

  • Describe risk management plans and risk minimisation measures, giving one example of routine and one of additional measures

  • Trace the actions following a serious safety concern, from assessment through variation, suspension or withdrawal

Your checkpoint

A one-page signal management workflow with a worked case showing detection, assessment, regulatory action and communication

Week 7

Market Surveillance and Control & Online Systems

  • Explain market surveillance activities, including sampling and testing programmes, and how non-compliant products are handled

  • Describe the recall classification system and outline the steps and timelines for a recall from notification to effectiveness check

  • Identify the falsified medicine risks and the checks used to verify a suspicious product

  • Navigate the online regulatory systems used for applications, submissions and safety reporting, and list the data fields each requires

  • Explain how electronic systems support traceability, including batch and product identification, and what a data integrity failure would look like

Your checkpoint

A mock recall plan with classification, notification steps and effectiveness check, plus a table of online system functions mapped to the regulatory tasks they support

Week 8

Registration and Marketing Authorisation (MA) & Licensing, Good Pharmacy Practice, Training & Continuing Professional Development (CPD) & Regulatory Inspections & Clinical Trials & Market Surveillance and Control & Vigilance (Pharmacovigilance) & Quality Control (Lab and Lot Release) & Online Systems

  • Synthesise all domains by writing short answers to two integrated scenarios that each span at least three domains

  • Revisit your weakest two domains using your own notes and correct any factual errors found

  • Complete a timed mixed-domain practice set and review every incorrect answer to its source rule

  • Consolidate a one-page summary sheet of key timelines, thresholds and reporting routes for final revision

  • Confirm exam-day logistics and rehearse the summary sheet from memory

Your checkpoint

A completed timed mixed practice set with a written error log, plus a final one-page timeline and threshold summary sheet

Milestones

Week 2: You can explain the MA procedure options and variation classes without notes and have finished the procedure comparison table

Week 4: You have completed the CPD record and premises self-audit, and can describe the inspection grading scheme and CAPA process

Week 6: You can state safety reporting timelines and routes from memory and have completed the signal management worked case

Week 8: You have scored your timed mixed practice set, logged every error with its cause, and can reproduce the timeline and threshold summary sheet from memory